These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24440272)

  • 21. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term maintenance of human induced pluripotent stem cells by automated cell culture system.
    Konagaya S; Ando T; Yamauchi T; Suemori H; Iwata H
    Sci Rep; 2015 Nov; 5():16647. PubMed ID: 26573336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks.
    Chen VC; Couture LA
    Methods Mol Biol; 2015; 1283():13-21. PubMed ID: 25537838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
    Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
    Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing Human Induced Pluripotent Stem Cell Expansion in Stirred-Suspension Culture.
    Meng G; Liu S; Poon A; Rancourt DE
    Stem Cells Dev; 2017 Dec; 26(24):1804-1817. PubMed ID: 29017378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
    Yamashita T; Miyamoto Y; Bando Y; Ono T; Kobayashi S; Doi A; Araki T; Kato Y; Shirakawa T; Suzuki Y; Yamauchi J; Yoshida S; Sato N
    PLoS One; 2017; 12(2):e0171947. PubMed ID: 28192470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-to-End Platform for Human Pluripotent Stem Cell Manufacturing.
    Pandey PR; Tomney A; Woon MT; Uth N; Shafighi F; Ngabo I; Vallabhaneni H; Levinson Y; Abraham E; Friedrich Ben-Nun I
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells as an appropriate feeder layer for prolonged in vitro culture of human induced pluripotent stem cells.
    Havasi P; Nabioni M; Soleimani M; Bakhshandeh B; Parivar K
    Mol Biol Rep; 2013 Apr; 40(4):3023-31. PubMed ID: 23283738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
    Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
    Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes.
    Tan X; Dai Q; Guo T; Xu J; Dai Q
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2490-2497. PubMed ID: 29217199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robust protocol for feeder-free adaptation of cryopreserved human pluripotent stem cells.
    Aalders J; Van den Vreken N; Popovic M; Mishra S; Heindryckx B; van Hengel J
    In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):777-783. PubMed ID: 31664691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells.
    Paull D; Sevilla A; Zhou H; Hahn AK; Kim H; Napolitano C; Tsankov A; Shang L; Krumholz K; Jagadeesan P; Woodard CM; Sun B; Vilboux T; Zimmer M; Forero E; Moroziewicz DN; Martinez H; Malicdan MC; Weiss KA; Vensand LB; Dusenberry CR; Polus H; Sy KT; Kahler DJ; Gahl WA; Solomon SL; Chang S; Meissner A; Eggan K; Noggle SA
    Nat Methods; 2015 Sep; 12(9):885-92. PubMed ID: 26237226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion.
    Du SH; Tay JC; Chen C; Tay FC; Tan WK; Li ZD; Wang S
    J Biosci Bioeng; 2015 Aug; 120(2):210-7. PubMed ID: 25622768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-Β1 regulation of pluripotency.
    Yamasaki S; Taguchi Y; Shimamoto A; Mukasa H; Tahara H; Okamoto T
    PLoS One; 2014; 9(1):e87151. PubMed ID: 24489856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system.
    Lu HE; Tsai MS; Yang YC; Yuan CC; Wang TH; Lin XZ; Tseng CP; Hwang SM
    Exp Cell Res; 2011 Aug; 317(13):1895-903. PubMed ID: 21640101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term maintenance of undifferentiated human embryonic and induced pluripotent stem cells in suspension.
    Larijani MR; Seifinejad A; Pournasr B; Hajihoseini V; Hassani SN; Totonchi M; Yousefi M; Shamsi F; Salekdeh GH; Baharvand H
    Stem Cells Dev; 2011 Nov; 20(11):1911-23. PubMed ID: 21198400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells.
    McGrath M; Tam E; Sladkova M; AlManaie A; Zimmer M; de Peppo GM
    Stem Cell Res Ther; 2019 Jan; 10(1):11. PubMed ID: 30635059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
    Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
    Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor.
    Abbasalizadeh S; Larijani MR; Samadian A; Baharvand H
    Tissue Eng Part C Methods; 2012 Nov; 18(11):831-51. PubMed ID: 22559864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.